These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5625134)

  • 1. The effects of topically applied biogenic monoamines on the isolated toad spinal cord.
    Tebĕcis AK; Phillis JW
    Comp Biochem Physiol; 1967 Nov; 23(2):553-63. PubMed ID: 5625134
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of topically applied cholinomimetic drugs on the isolated spinal cord of the toad.
    Phillis JW; Tebĕcis AK
    Comp Biochem Physiol; 1967 Nov; 23(2):541-52. PubMed ID: 6080512
    [No Abstract]   [Full Text] [Related]  

  • 3. Spinal monoamines and the toxic interaction between monoamine oxidase inhibitors and tricyclic antidepressants.
    Clineschmidt BV
    Eur J Pharmacol; 1972 Jul; 19(1):126-9. PubMed ID: 4403107
    [No Abstract]   [Full Text] [Related]  

  • 4. The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity.
    Reimann W; Schneider F
    Gen Pharmacol; 1993 Mar; 24(2):449-53. PubMed ID: 8482527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins and toad spinal cord responses.
    Phillis JW; Tebecis AK
    Nature; 1968 Mar; 217(5133):1076-7. PubMed ID: 5643538
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of drugs on inhibitory synapses.
    Krnjević K
    Adv Cytopharmacol; 1971 May; 1():419-26. PubMed ID: 4356765
    [No Abstract]   [Full Text] [Related]  

  • 7. Microiontophoresis of 5-hydroxytryptamine, epinephrine, and prostaglandin E1 on spinal neurons in the frog.
    Caulford PG; Coceani F
    Can J Physiol Pharmacol; 1977 Apr; 55(2):293-300. PubMed ID: 301425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of histamine on the toad spinal cord.
    Tebēcis AK; Tebcis AK
    Nature; 1970 Jan; 225(5228):196-7. PubMed ID: 5409972
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoaminergic establishment of rostrocaudal gradients of rhythmicity in the neonatal mouse spinal cord.
    Christie KJ; Whelan PJ
    J Neurophysiol; 2005 Aug; 94(2):1554-64. PubMed ID: 15829596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoneural blocking effect of some monoamine oxidase inhibitors.
    Dutta SN; Pradhan SN
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):188-95. PubMed ID: 5834933
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices.
    Bourgoin S; Pohl M; Mauborgne A; Benoliel JJ; Collin E; Hamon M; Cesselin F
    Neuropharmacology; 1993 Jul; 32(7):633-40. PubMed ID: 7689707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative aspects of selected psychoactive compounds: biogenic amines, monoamine oxidase inhibitors, and lysergic acid diethylamide.
    Pscheidt GR
    Comp Biochem Physiol; 1968 Jan; 24(1):249-65. PubMed ID: 4868883
    [No Abstract]   [Full Text] [Related]  

  • 13. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
    Gorkin VZ; Romanova LA
    Biochem Pharmacol; 1968 Jun; 17(6):855-60. PubMed ID: 5661349
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.
    Azzaro AJ; Amedro JB; Brown LM; Smith DJ; Williams GM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):9-13. PubMed ID: 2467212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoamines and the central nervous system. I. Photomyoclonic threshold and serotonin].
    Peniche JH; Valverde C; Ramírez del Angel A; Rodón E; Saravia J
    Rev Invest Clin; 1966; 18(3):413-23. PubMed ID: 4295835
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of reserpine and monoamine oxidase inhibition on the levels of amino acids in sensory ganglia, sympathetic ganglia and spinal cord.
    Santini M; Berl S
    Brain Res; 1972 Nov; 47(1):167-76. PubMed ID: 4641266
    [No Abstract]   [Full Text] [Related]  

  • 17. [An electrophysiological analysis of the functional interaction of serotonin and gamma-aminobutyric acid on the segmentary level of the spinal cord].
    Romanova GA
    Biull Eksp Biol Med; 1967 Oct; 63(10):47-50. PubMed ID: 5622280
    [No Abstract]   [Full Text] [Related]  

  • 18. Responses of spinal cord interneurons to acetylcholine, norepinephrine and serotonin administered by microelectrophoresis.
    Weight FF; Salmoiraghi GC
    J Pharmacol Exp Ther; 1966 Sep; 153(3):420-7. PubMed ID: 5922319
    [No Abstract]   [Full Text] [Related]  

  • 19. Bulbospinal serotonin-containing neurons and motor control.
    Anderson EG
    Fed Proc; 1972; 31(1):107-12. PubMed ID: 4333246
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monoamines and endogenous depression. Biochemical and pharmacological aspects].
    Scuvée-Moreau J; Dresse A
    Rev Med Liege; 1982 Jan; 37(1):1-7. PubMed ID: 7054862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.